Cargando…

Stem Cell Therapy in Injured Vocal Folds: A Three-Month Xenograft Analysis of Human Embryonic Stem Cells

We have previously shown that human embryonic stem cell (hESC) therapy to injured rabbit vocal folds (VFs) induces human tissue generation with regained VF vibratory capacity. The aims of this study were to test the sustainability of such effect and to what extent derivatives of the transplanted hES...

Descripción completa

Detalles Bibliográficos
Autores principales: Svensson, Bengt, Nagubothu, Srinivasa R., Nord, Christoffer, Cedervall, Jessica, Hultman, Isabell, Ährlund-Richter, Lars, Tolf, Anna, Hertegård, Stellan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4628720/
https://www.ncbi.nlm.nih.gov/pubmed/26557696
http://dx.doi.org/10.1155/2015/754876
_version_ 1782398478855438336
author Svensson, Bengt
Nagubothu, Srinivasa R.
Nord, Christoffer
Cedervall, Jessica
Hultman, Isabell
Ährlund-Richter, Lars
Tolf, Anna
Hertegård, Stellan
author_facet Svensson, Bengt
Nagubothu, Srinivasa R.
Nord, Christoffer
Cedervall, Jessica
Hultman, Isabell
Ährlund-Richter, Lars
Tolf, Anna
Hertegård, Stellan
author_sort Svensson, Bengt
collection PubMed
description We have previously shown that human embryonic stem cell (hESC) therapy to injured rabbit vocal folds (VFs) induces human tissue generation with regained VF vibratory capacity. The aims of this study were to test the sustainability of such effect and to what extent derivatives of the transplanted hESCs are propagated in the VFs. The VFs of 14 New Zealand rabbits were injured by a localized resection. HESCs were transplanted to 22 VFs which were analyzed for persistence of hESCs after six weeks and after three months. At three months, the VFs were also analyzed for viscoelasticity, measured as dynamic viscosity and elastic modulus, for the lamina propria (Lp) thickness and relative content of collagen type I. Three months after hESC cell therapy, the dynamic viscosity and elastic modulus of the hESC treated VFs were similar to normal controls and lower than untreated VFs (p ≤ 0.011). A normalized VF architecture, reduction in collagen type I, and Lp thickness were found compared with untreated VFs (p ≤ 0.031). At three months, no derivatives of hESCs were detected. HESCs transplanted to injured rabbit VFs restored the vibratory characteristics of the VFs, with maintained restored function for three months without remaining hESCs or derivatives.
format Online
Article
Text
id pubmed-4628720
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-46287202015-11-09 Stem Cell Therapy in Injured Vocal Folds: A Three-Month Xenograft Analysis of Human Embryonic Stem Cells Svensson, Bengt Nagubothu, Srinivasa R. Nord, Christoffer Cedervall, Jessica Hultman, Isabell Ährlund-Richter, Lars Tolf, Anna Hertegård, Stellan Biomed Res Int Research Article We have previously shown that human embryonic stem cell (hESC) therapy to injured rabbit vocal folds (VFs) induces human tissue generation with regained VF vibratory capacity. The aims of this study were to test the sustainability of such effect and to what extent derivatives of the transplanted hESCs are propagated in the VFs. The VFs of 14 New Zealand rabbits were injured by a localized resection. HESCs were transplanted to 22 VFs which were analyzed for persistence of hESCs after six weeks and after three months. At three months, the VFs were also analyzed for viscoelasticity, measured as dynamic viscosity and elastic modulus, for the lamina propria (Lp) thickness and relative content of collagen type I. Three months after hESC cell therapy, the dynamic viscosity and elastic modulus of the hESC treated VFs were similar to normal controls and lower than untreated VFs (p ≤ 0.011). A normalized VF architecture, reduction in collagen type I, and Lp thickness were found compared with untreated VFs (p ≤ 0.031). At three months, no derivatives of hESCs were detected. HESCs transplanted to injured rabbit VFs restored the vibratory characteristics of the VFs, with maintained restored function for three months without remaining hESCs or derivatives. Hindawi Publishing Corporation 2015 2015-10-18 /pmc/articles/PMC4628720/ /pubmed/26557696 http://dx.doi.org/10.1155/2015/754876 Text en Copyright © 2015 Bengt Svensson et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Svensson, Bengt
Nagubothu, Srinivasa R.
Nord, Christoffer
Cedervall, Jessica
Hultman, Isabell
Ährlund-Richter, Lars
Tolf, Anna
Hertegård, Stellan
Stem Cell Therapy in Injured Vocal Folds: A Three-Month Xenograft Analysis of Human Embryonic Stem Cells
title Stem Cell Therapy in Injured Vocal Folds: A Three-Month Xenograft Analysis of Human Embryonic Stem Cells
title_full Stem Cell Therapy in Injured Vocal Folds: A Three-Month Xenograft Analysis of Human Embryonic Stem Cells
title_fullStr Stem Cell Therapy in Injured Vocal Folds: A Three-Month Xenograft Analysis of Human Embryonic Stem Cells
title_full_unstemmed Stem Cell Therapy in Injured Vocal Folds: A Three-Month Xenograft Analysis of Human Embryonic Stem Cells
title_short Stem Cell Therapy in Injured Vocal Folds: A Three-Month Xenograft Analysis of Human Embryonic Stem Cells
title_sort stem cell therapy in injured vocal folds: a three-month xenograft analysis of human embryonic stem cells
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4628720/
https://www.ncbi.nlm.nih.gov/pubmed/26557696
http://dx.doi.org/10.1155/2015/754876
work_keys_str_mv AT svenssonbengt stemcelltherapyininjuredvocalfoldsathreemonthxenograftanalysisofhumanembryonicstemcells
AT nagubothusrinivasar stemcelltherapyininjuredvocalfoldsathreemonthxenograftanalysisofhumanembryonicstemcells
AT nordchristoffer stemcelltherapyininjuredvocalfoldsathreemonthxenograftanalysisofhumanembryonicstemcells
AT cedervalljessica stemcelltherapyininjuredvocalfoldsathreemonthxenograftanalysisofhumanembryonicstemcells
AT hultmanisabell stemcelltherapyininjuredvocalfoldsathreemonthxenograftanalysisofhumanembryonicstemcells
AT ahrlundrichterlars stemcelltherapyininjuredvocalfoldsathreemonthxenograftanalysisofhumanembryonicstemcells
AT tolfanna stemcelltherapyininjuredvocalfoldsathreemonthxenograftanalysisofhumanembryonicstemcells
AT hertegardstellan stemcelltherapyininjuredvocalfoldsathreemonthxenograftanalysisofhumanembryonicstemcells